IMPAKT 2017

Oncology Meeting Resources

04 May - 06 May 2017, Brussels, Belgium

IMPAKT 2017 breast cancer conference

IMPAKT 2017 Breast Cancer Conference was designed for breast cancer researchers and clinicians who have a specific interest in translational research, new agents, molecular and functional diagnostics, biomarkers and cutting-edge research applications in the clinical setting.

Resources from IMPAKT 2017 Breast Cancer Conference are available to ESMO member according to the presenters' agreement to release them. The use of these presentations is for personal educational purposes only. ESMO and BIG thank the authors for their generosity.

Download the IMPAKT 2017 Scientific report

ESMO Scientific videos from IMPAKT 2017

Useful links





Format available

http://oncologypro.esmo.org/Meeting-Resourc...2017/Defining-the-endpoints-of-your-research

Date: 04 May 2017
Presenter: Elia Biganzoli
Resources: Presentation, Webcast
Topic: Breast Cancer

http://oncologypro.esmo.org/Meeting-Resources/IMPAKT-2017/Basics-in-clinical-trial-design

Date: 04 May 2017
Presenter: Monica Arnedos
Resources: Presentation, Webcast
Topic: Breast Cancer

http://oncologypro.esmo.org/Meeting-Resourc...processing-in-the-context-of-clinical-trials

Date: 04 May 2017
Presenter: Bruno Sinn
Resources: Presentation, Webcast
Topic: Breast Cancer

http://oncologypro.esmo.org/Meeting-Resources/IMPAKT-2017/Early-drug-development

Date: 04 May 2017
Presenter: Nick Turner
Resources: Presentation, Webcast
Topics: Anti-Cancer Agents & Biologic Therapy, Drug Development, Breast Cancer

http://oncologypro.esmo.org/Meeting-Resourc...es-Are-these-two-mutual-exclusive-strategies

Date: 04 May 2017
Presenter: Fabrice André
Resources: Presentation, Webcast
Topics: Breast Cancer, Cancer Immunology and Immunotherapy

http://oncologypro.esmo.org/Meeting-Resources/IMPAKT-2017/Triple-combinations-in-ER-mBC

Date: 04 May 2017
Presenter: Dejan Juric
Resources: Presentation, Webcast
Topics: Breast Cancer, Translational Research

http://oncologypro.esmo.org/Meeting-Resources/IMPAKT-2017/The-role-of-ESR-1-mutations

Date: 04 May 2017
Presenter: Aleix Prat
Resources: Presentation, Webcast
Topics: Breast Cancer, Translational Research

http://oncologypro.esmo.org/Meeting-Resourc...ted-therapeutic-strategies-for-breast-cancer

Date: 04 May 2017
Presenter: René Bernards
Resources: Presentation, Webcast
Topics: Breast Cancer, Translational Research

http://oncologypro.esmo.org/Meeting-Resourc...-HER2-ABC-Efficacy-by-baseline-tumor-markers

BodyBackground: Cyclin D–cyclin-dependent kinase (CDK) 4/6 complexes promote cell proliferation through retinoblastoma protein (Rb) phosphorylation. Cyclin D gene (CCND1) amplification or loss of...

Date: 04 May 2017
Presenter: Fabrice André
Resources: Abstract
Topics: Breast Cancer, Translational Research

http://oncologypro.esmo.org/Meeting-Resourc...-with-TDM1-for-metastatic-HER2-breast-cancer

BodyPURPOSE: HER2+ breast cancer is treated using agents that target the amplified receptor. Such drugs are effective; however, recurrence and progression can occur in spite of multiple HER2-targeted therapies.

Date: 04 May 2017
Presenter: Erik Knudsen
Resources: Abstract
Topic: Breast Cancer